Redoxon orange 1g, Brausetabletten

7680563540057 CH-56354 Brausetabletten
Redoxon orange 1g, Brausetabletten
Redoxon orange 1g, Brausetabletten
1 / 2
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Brausetabletten
Galenic group
Brausetabletten

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 G Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
900.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
34.2 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
15.0 MG Substance HBESI
(N/A)
- Substance FTODK
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
20.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
312.0 MG Substance HBESI

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
56354
Drug name
Redoxon orange 1g, Brausetabletten
Galenic form
BRAT
ATC Code
A11GA01
Authorization status
Z
Dispensing category
D
First authorization
15/09/2005
Authorization expiration date
31/12/9999
IT Number
07.02.3.
Domain
Human medicine
Field of application
Vitamin C Präparat

Package details

Description (FR)
REDOXON cpr eff 1 g orange 30 pce
Description (DE)
REDOXON Brausetabl 1 g orange 30 Stk
Market launch
15/09/2005
Narcotic (BTM)
No